What are anticardiolipine antibodies?

Anticardiolipine antibodies are antibodies that create the body to target cardiolipine and phospholipid. Cardiolipine is part of the inner part of the mitochondrial membrane in cells. Phospholipid is a main part of the cell wall. Antibodies directly attack cardiolipine and phospholipid cell walls. Although many people suffer from symptoms because there is a condition present, some people may not have symptoms at all. It is often diagnosed when symptoms occur and become particularly annoying to the suffering. These blood clots can be found in the legs, vital organs and brain. The clots in the legs are known as deep venous thrombosis. Vital organs such as lungs, kidneys or hearts may suffer damage and lead the organs. When clots occur in the brain, neurological symptoms or stroke are likely.

Testing only can confirm the presence of anticardiolipine antibodies. Blood tests can help cancel antibodies. It is likely that the specialist will order the testing JAko diagnostic measures when trying to find the exact cause of the clot. For example, a gynecologist or obstetrician orders a test if an abortion or pregnancy is complicated, and the hematologist will look for the cause of the foot clots.

Blood testing of anticardiolipine antibodies is performed more than once. If there are multiple clots or pregnancy problems, the doctor will order testing. In general, two tests are performed and are 12 weeks apart and antibodies must be present occasionally to confirm the diagnosis. In some cases, more than two tests are required, which will also be distributed 12 Weeks apart.

If blood clots occur as a result of the basic condition, treatment of this condition must be initiated. Treatment of recurring clots is also recommended. In many cases, doctors prescribe blood thinners to prevent clots. There is also useful low -dose aspirin therapy.

Monitoring is essential. Patients about medicines must be monitored by bleeding because blood thinners prevent blood clotting. Small injury can be dangerous. Patients must also be monitored on new clots or serious damage by existing clots. Women who are pregnant and take medication receive regular monitoring and controls to monitor the health of the unborn child.